TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
VTGN

VistaGen Therapeutics Inc

Healthcare · Biotechnology

0.2336$ +1.3% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for VistaGen Therapeutics Inc (VTGN): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/06/2026.

Next report 08/06/2026
Last report 08/14/2026
Earnings surprise by quarter (%)
Q3 23 · 2.9 % 23 Q4 23 · 18.5 % 23 Q1 24 · 30.6 % 24 Q2 24 · 12.5 % 24 Q3 24 · -7.7 % 24 Q4 24 · 11.5 % 24 Q1 25 · 48.2 % 25 Q2 25 · 0.0 % 25 Q3 25 · -22.7 % 25 Q4 25 · 6.3 % 25 Q1 26 · 11.9 % 26 Q2 26 · -3.5 % 26

EPS estimate beaten

Full history 22 of 44 quarters (50%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/10/2026 Vistagen Therapeutics, Inc. (VTGN): Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/14/2026 Vistagen Therapeutics, Inc. (VTGN): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 Vistagen Therapeutics, Inc. (VTGN): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/05/2026 Vistagen Therapeutics, Inc. (VTGN): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗
  • 07/31/2026 Vistagen Therapeutics, Inc. (VTGN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?